155 related articles for article (PubMed ID: 36424777)
1. The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies.
Latacela GA; Ramaiah P; Patra I; Jalil AT; Gupta R; Madaminov FA; Shaker Shafik S; Al-Gazally ME; Ansari MJ; Kandeel M; Mustafa YF; Farhood B
Curr Med Chem; 2023; 30(33):3775-3797. PubMed ID: 36424777
[TBL] [Abstract][Full Text] [Related]
2. The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.
Gupta J; Turki Jalil A; Al-Hawraa Riyad Muedii Z; Aminov Z; Alsaikhan F; Ramírez-Coronel A; Ramaiah P; Farhood B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921180
[TBL] [Abstract][Full Text] [Related]
3. The radioprotective effects of alpha-lipoic acid on radiotherapy-induced toxicities: A systematic review.
Sheikholeslami S; Khodaverdian S; Dorri-Giv M; Mohammad Hosseini S; Souri S; Abedi-Firouzjah R; Zamani H; Dastranj L; Farhood B
Int Immunopharmacol; 2021 Jul; 96():107741. PubMed ID: 33989970
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity.
Singh M; Kadhim MM; Turki Jalil A; Oudah SK; Aminov Z; Alsaikhan F; Jawhar ZH; Ramírez-Coronel AA; Farhood B
Cancer Cell Int; 2023 May; 23(1):88. PubMed ID: 37165384
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Effect of Silymarin and Silibinin on Depression and Anxiety Disorders and Possible Mechanism in the Brain: A Systematic Review.
Rostamian S; Heidari-Soureshjani S; Sherwin CMT
Cent Nerv Syst Agents Med Chem; 2023; 23(2):86-94. PubMed ID: 37612866
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Mechanisms of
Ghahfarrokhi SH; Heidari-Soureshjani S; Sherwin CMT; Azadegan-Dehkordi Z
Curr Rheumatol Rev; 2024; 20(4):414-425. PubMed ID: 38314596
[TBL] [Abstract][Full Text] [Related]
7. The Protective Effects of Silymarin on the Reproductive Toxicity: A Comprehensive Review.
Hariyanti T; Margiana R; Al-Gazally ME; Patra I; Lateef Al-Awsi GR; Hameed N; Kayumova D; Ansari MJ; Torres-Criollo LM; Mustafa YF; Abedi-Firouzjah R; Farhood B
Curr Med Chem; 2023; 30(39):4421-4449. PubMed ID: 36717999
[TBL] [Abstract][Full Text] [Related]
8. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data.
Ghodousi M; Karbasforooshan H; Arabi L; Elyasi S
Eur J Clin Pharmacol; 2023 Jan; 79(1):15-38. PubMed ID: 36450892
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implications.
Shen L; Liu L; Li XY; Ji HF
Appl Microbiol Biotechnol; 2019 Sep; 103(17):7141-7149. PubMed ID: 31236617
[TBL] [Abstract][Full Text] [Related]
11. Silymarin versus Silibinin: Differential Antioxidant and Neuroprotective Effects against H2O2-induced Oxidative Stress in PC12 Cells.
Jiang HH; Yan FS; Shen L; Ji HF
Nat Prod Commun; 2016 May; 11(5):633-6. PubMed ID: 27319137
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Ravichandran K; Velmurugan B; Gu M; Singh RP; Agarwal R
Clin Cancer Res; 2010 Sep; 16(18):4595-606. PubMed ID: 20823143
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
14. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms.
Musazadeh V; Karimi A; Bagheri N; Jafarzadeh J; Sanaie S; Vajdi M; Karimi M; Niazkar HR
Biomed Pharmacother; 2022 Oct; 154():113593. PubMed ID: 36027611
[TBL] [Abstract][Full Text] [Related]
15. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.
Singh RP; Tyagi AK; Zhao J; Agarwal R
Carcinogenesis; 2002 Mar; 23(3):499-510. PubMed ID: 11895866
[TBL] [Abstract][Full Text] [Related]
16. Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis.
Kauntz H; Bousserouel S; Gosse F; Marescaux J; Raul F
Int J Oncol; 2012 Sep; 41(3):849-54. PubMed ID: 22735354
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
18. Silibinin inhibits ultraviolet B radiation-induced DNA-damage and apoptosis by enhancing interleukin-12 expression in JB6 cells and SKH-1 hairless mouse skin.
Narayanapillai S; Agarwal C; Deep G; Agarwal R
Mol Carcinog; 2014 Jun; 53(6):471-9. PubMed ID: 23359305
[TBL] [Abstract][Full Text] [Related]
19. Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.
Choi ES; Oh S; Jang B; Yu HJ; Shin JA; Cho NP; Yang IH; Won DH; Kwon HJ; Hong SD; Cho SD
Cell Oncol (Dordr); 2017 Jun; 40(3):235-246. PubMed ID: 28401485
[TBL] [Abstract][Full Text] [Related]
20. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
